Department of State, 2005
may improve insulin, adiponectin, and inflammatory markers Clinical Use Cases : Fatty liver, leptin resistance, or stress-induced overeating patterns May indirectly improve inflammation, sleep apnea, and fatigue via fat mass reduction Cautions : Risk of nausea, delayed gastric emptying, or gallbladder issues
Enhanced Sleep Quality MK-677 demonstrates significant effects on sleep patterns by increasing deep sleep duration
This approach, in North America, has been largely evaluated for the prevention and extended-duration treatment of VTE, and for cardiovascular risk reduction in patients with stable atherosclerotic cardiovascular disease (ASCVD) or after recent revascularization for peripheral arterial disease (PAD)